Shuichi Hironaka
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.
Journal: Targeted oncology
Published: November 17, 2025
Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST).
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 14, 2025
Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan.
Journal: EClinicalMedicine
Published: October 11, 2025
Two cases of metastatic colorectal cancer in which epidermal growth factor receptor gene amplification benefited from panitumumab monotherapy.
Journal: International cancer conference journal
Published: July 18, 2025
Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: June 30, 2025
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2025
Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advances.
Journal: Japanese journal of clinical oncology
Published: February 27, 2025
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: October 01, 2024
A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).
Journal: Cancer
Published: August 29, 2024
Promising Objective Response Rates and Progression-Free Survival but Modest Overall Survival in the TAB Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 12, 2024
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.
Journal: Targeted oncology
Published: February 05, 2024
Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in japan: a retrospective database cohort study.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: December 06, 2023
Last Updated: 09/26/2026